Adial Pharmaceuticals, Inc. (Adial) has announced the upcoming 2024 Annual Meeting of Stockholders to be held on November 12, 2024. The meeting will address several key proposals, including the election of two Class III directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of an amendment to increase the number of shares available under the 2017 Equity Incentive Plan from 500,000 to 2,000,000. Additionally, advisory votes will be held on executive compensation and the frequency of future advisory votes on executive compensation. The Board of Directors has fixed September 26, 2024, as the record date for determining stockholders entitled to notice and vote at the meeting. Proxy materials, including the Annual Report on Form 10-K for the year ended December 31, 2023, will be mailed to stockholders around October 3, 2024. The Board recommends voting for all the proposals and has provided detailed information regarding the meeting's agenda, executive compensation, and related-party transactions.

Adial Pharmaceuticals, Inc. (Adial) has announced the upcoming 2024 Annual Meeting of Stockholders to be held on November 12, 2024. The meeting will address several key proposals, including the election of two Class III directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of an amendment to increase the number of shares available under the 2017 Equity Incentive Plan from 500,000 to 2,000,000. Additionally, advisory votes will be held on executive compensation and the frequency of future advisory votes on executive compensation. The Board of Directors has fixed September 26, 2024, as the record date for determining stockholders entitled to notice and vote at the meeting. Proxy materials, including the Annual Report on Form 10-K for the year ended December 31, 2023, will be mailed to stockholders around October 3, 2024. The Board recommends voting for all the proposals and has provided detailed information regarding the meeting's agenda, executive compensation, and related-party transactions.